New England Capital Financial Advisors’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-666
Closed -$6.11K 425
2025
Q1
$6.11K Hold
666
﹤0.01% 268
2024
Q4
$276 Buy
+666
New +$5.86K ﹤0.01% 388

New England Capital Financial Advisors's OPTN Position: Q2 2025 in Review

New England Capital Financial Advisors sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 666 shares — an estimated $6.11K sold.

New England Capital Financial Advisors first reported a position in OPTN in Q4 2024 and held it in 2 quarters. The position peaked at $6.11K in Q1 2025. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.

  • New England Capital Financial Advisors reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
  • New England Capital Financial Advisors sold 666 OptiNose shares in Q2 2025, an estimated $6.11K.
  • New England Capital Financial Advisors first reported a position in OptiNose in Q4 2024 and held it in 2 quarters.
  • New England Capital Financial Advisors's OptiNose position peaked at $6.11K in Q1 2025.
  • 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.

Based on New England Capital Financial Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.